In rifampicin-resistant TB, bedaquiline-containing regimens reduced unfavorable status vs. a control regimen at 132 wk

Authors

Institutions

Publication Details

Journal
Annals of Internal Medicine
Published
2025-02-01
DOI
https://doi.org/10.7326/annals-24-03918-jc
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

In rifampicin-resistant TB, bedaquiline-containing regimens reduced unfavorable status vs. a control regimen at 132 wk

Zain Chagla, Alex Nachman
Annals of Internal Medicine
Tuberculosis Research and Epidemiology
article

In rifampicin-resistant TB, bedaquiline-containing regimens reduced unfavorable status vs. a control regimen at 132 wk

Zain Chagla, Alex Nachman
article en

Abstract

No abstract available for this paper.
Annals of Internal MedicineVol. 178(2)
McMaster University (CA)
Zero hunger
Openalex Percentile: Top 97%
Tuberculosis Research and Epidemiology
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

In rifampicin-resistant TB, bedaquiline-containing regimens reduced unfavorable status vs. a control regimen at 132 wk — Zain Chagla, Alex Nachman · Annals of Internal Medicine (2025) | TGRS Research Map | TGRS